Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.

The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence to autoimmune disorders such as multiple sclerosis. Stemming from several studies that demonstrate that mice can be protected from experimental autoimmune encephalomyelitis (EAE) through the pharmacologic in...

Full description

Bibliographic Details
Main Authors: Euan Ramsay Orr Allan, Robin Michael Yates
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4468166?pdf=render
_version_ 1818532915053592576
author Euan Ramsay Orr Allan
Robin Michael Yates
author_facet Euan Ramsay Orr Allan
Robin Michael Yates
author_sort Euan Ramsay Orr Allan
collection DOAJ
description The cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence to autoimmune disorders such as multiple sclerosis. Stemming from several studies that demonstrate that mice can be protected from experimental autoimmune encephalomyelitis (EAE) through the pharmacologic inhibition of cysteine cathepsins, it has been suggested that targeting these enzymes in multiple sclerosis may be of therapeutic benefit. Utilizing mice deficient in cysteine cathepsins both individually and in combination, we found that the myelin-associated antigen myelin oligodendrocyte glycoprotein (MOG) was efficiently processed and presented by macrophages to CD4+ T cells in the individual absence of cathepsin B, S or L. Similarly, mice deficient in cathepsin B or S were susceptible to MOG-induced EAE and displayed clinical progression and immune infiltration into the CNS, similar to their wild-type counterparts. Owing to a previously described CD4+ T cell deficiency in mice deficient in cathepsin L, such mice were protected from EAE. When multiple cysteine cathepsins were simultaneously inhibited via genetic deletion of both cathepsins B and S, or by a cathepsin inhibitor (LHVS), MHC-II surface expression, MOG antigen presentation and EAE were attenuated or prevented. This study demonstrates the functional redundancy between cathepsin B, S and L in EAE, and suggests that the inhibition of multiple cysteine cathepsins may be needed to modulate autoimmune disorders such as multiple sclerosis.
first_indexed 2024-12-11T17:51:46Z
format Article
id doaj.art-5364e9f8636648da800b996c3b37f44d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T17:51:46Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5364e9f8636648da800b996c3b37f44d2022-12-22T00:56:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01106e012894510.1371/journal.pone.0128945Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.Euan Ramsay Orr AllanRobin Michael YatesThe cysteine cathepsins B, S, and L are functionally linked to antigen processing, and hence to autoimmune disorders such as multiple sclerosis. Stemming from several studies that demonstrate that mice can be protected from experimental autoimmune encephalomyelitis (EAE) through the pharmacologic inhibition of cysteine cathepsins, it has been suggested that targeting these enzymes in multiple sclerosis may be of therapeutic benefit. Utilizing mice deficient in cysteine cathepsins both individually and in combination, we found that the myelin-associated antigen myelin oligodendrocyte glycoprotein (MOG) was efficiently processed and presented by macrophages to CD4+ T cells in the individual absence of cathepsin B, S or L. Similarly, mice deficient in cathepsin B or S were susceptible to MOG-induced EAE and displayed clinical progression and immune infiltration into the CNS, similar to their wild-type counterparts. Owing to a previously described CD4+ T cell deficiency in mice deficient in cathepsin L, such mice were protected from EAE. When multiple cysteine cathepsins were simultaneously inhibited via genetic deletion of both cathepsins B and S, or by a cathepsin inhibitor (LHVS), MHC-II surface expression, MOG antigen presentation and EAE were attenuated or prevented. This study demonstrates the functional redundancy between cathepsin B, S and L in EAE, and suggests that the inhibition of multiple cysteine cathepsins may be needed to modulate autoimmune disorders such as multiple sclerosis.http://europepmc.org/articles/PMC4468166?pdf=render
spellingShingle Euan Ramsay Orr Allan
Robin Michael Yates
Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
PLoS ONE
title Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
title_full Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
title_fullStr Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
title_full_unstemmed Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
title_short Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
title_sort redundancy between cysteine cathepsins in murine experimental autoimmune encephalomyelitis
url http://europepmc.org/articles/PMC4468166?pdf=render
work_keys_str_mv AT euanramsayorrallan redundancybetweencysteinecathepsinsinmurineexperimentalautoimmuneencephalomyelitis
AT robinmichaelyates redundancybetweencysteinecathepsinsinmurineexperimentalautoimmuneencephalomyelitis